Infusystem holdings, inc (INFU)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
OPERATING ACTIVITIES
Net income (loss)

1,361

-1,095

-20,707

-222

2,785

3,357

1,669

-1,489

-45,443

-1,852

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Gain on derivative liabilities

-

-

-

-

-

-

-

-

83

207

Loss on extinguishment of long-term debt

-

-

-

-

-1,599

-

-

-671

-

1,118

Provision for doubtful accounts

37

-218

5,641

5,631

5,234

5,774

6,534

5,251

4,099

4,515

Depreciation

7,940

6,659

6,963

6,895

5,359

3,626

5,415

5,668

6,386

5,357

Loss on disposal of medical equipment

638

434

207

641

-

-

-

-

-

-

Loss/(gain) on disposal of medical equipment

-

-

-

-

591

281

-47

237

1,731

-

Gain on sale of medical equipment

1,453

1,340

1,662

1,231

2,441

2,179

2,027

1,964

2,753

-

Loss on disposal of pumps

-

-

-

-

-

-

-

-

-

-994

Amortization of intangible assets

4,402

4,649

5,560

3,849

2,884

2,516

2,618

2,734

2,662

2,259

Asset impairment charges

-

-

993

0

-

-

-

-

67,592

-

Amortization of deferred debt issuance costs

37

33

28

31

127

623

620

228

238

980

Stock-based compensation expense

997

957

682

462

996

576

1,120

964

1,185

3,860

Deferred income tax expense (benefit)

104

-62

15,389

-240

1,137

2,588

1,180

-906

-23,423

-1,236

Changes in Assets - (Increase)/Decrease:
Accounts receivable

1,560

-1,909

5,344

4,589

7,556

5,377

8,720

6,490

4,419

3,948

Inventories

645

490

-402

250

158

524

-105

30

-33

-

Other current assets

290

222

201

88

228

115

-166

-249

184

506

Other assets

129

6

-119

-166

497

-140

92

-664

-657

173

Changes in Liabilities - Increase:
Accounts payable and other liabilities

2,436

183

-352

-3,146

-2,778

-4,031

-1,078

-335

-1,532

2,252

Derivative liabilities from termination of interest rate swap

-

-

-

-

-

-

-

-

-

365

NET CASH PROVIDED BY OPERATING ACTIVITIES

13,875

11,391

7,718

7,909

-

-

-

5,452

6,746

10,812

INVESTING ACTIVITIES
Purchases of medical equipment

19,669

8,022

-

-

-

-

-

-

-

-

NET CASH PROVIDED BY OPERATING ACTIVITIES

-

-

-

-

7,054

7,255

7,463

-

-

-

Acquisitions

-

-

-

370

6,156

-

-

-

-

-

Purchase of medical equipment and property

-

-

2,652

5,101

4,198

4,167

-

6,542

8,211

2,444

Purchases of property and equipment

2,926

281

104

168

314

1,995

4,723

-

-

-

Purchases of intangible assets

-

-

192

3,526

5,733

3,543

1,239

-

625

-

Proceeds from sale of medical equipment and property

2,952

3,319

3,866

3,821

4,494

6,867

3,800

3,978

4,218

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-

-

-

-

-11,907

-2,838

-2,162

-

-

-

Other asset acquisitions

-

-

-

-

-

-

-

6

-509

-

Other asset acquisitions

-

-

-

-

-

-

-

-

-

16,616

NET CASH USED IN INVESTING ACTIVITIES

-19,643

-4,984

918

-5,344

-

-

-

-2,558

-5,127

-19,060

FINANCING ACTIVITIES
Principal payments on term loans, equipment line, revolving credit facility and other financing

4,868

6,319

37,466

66,999

-

-

-

-

-

-

Cash proceeds from 2019 equipment line and revolving credit facility

9,436

11,162

-

-

-

-

-

-

-

-

Cash proceeds from bank loans and revolving credit facility

-

-

28,866

66,892

-

-

-

-

-

-

Principal payments on revolving credit facility, term loans and capital lease obligations

-

-

-

-

65,202

66,689

4,504

9,631

5,953

822

Payoff of bank loan and revolver

-

-

-

-

-

-

-

25,851

-

-

Principal payments on debt

-

-

-

-

-

-

-

-

-

22,623

Cash proceeds from revolving credit facility

-

-

-

-

70,429

61,853

36,166

37,101

2,334

30,000

Debt issuance costs

6

27

38

7

157

-

-

2,842

-

808

Payments on revolving credit facility

-

-

-

-

-

-

38,072

-

1,750

-

Common stock repurchased to satisfy taxes on stock based compensation

-

-

-

-

-

-

-

-

102

167

Common stock repurchased as part of Repurchase Program

-

10,395

-

-

179

204

79

144

363

68

Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans

717

70

58

75

-

-

-

-

-

-

Cash proceeds - stock plans

252

91

131

204

265

-

-

-

-

-

NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

5,156

-5,040

-6,489

-

-

-

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

4,097

-5,558

-8,565

15

-

-

-

-1,367

-5,834

5,512

Net change in cash and cash equivalents

-1,671

849

71

2,580

303

-623

-1,188

1,527

-4,215

-2,736

SUPPLEMENTAL DISCLOSURES
Cash paid for interest

1,705

1,383

1,200

1,234

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

1,508

2,351

2,668

3,112

1,934

2,372

Cash paid for income taxes

111

159

139

105

146

298

549

79

249

21

NON-CASH TRANSACTIONS
Additions to medical equipment and property

2,773

998

549

429

1,415

920

266

121

1,008

903

Medical equipment acquired pursuant to a capital lease

-

-

137

2,675

4,233

3,596

2,541

522

2,300

1,869

Tender offer to exchange warrants

-

-

-

-

-

-

-

-

-

2,016

Origination of long term debt

-

-

-

-

-

-

-

-

-

750

Current assets assumed in acquisition

-

-

-

-

-

-

-

-

-

2,352

Current liabilities assumed in acquisition

-

-

-

-

-

-

-

-

-

438

Deferred tax liability assumed in acquisition

-

-

-

-

-

-

-

-

-

2,754

Deferred tax asset assumed in acquisition

-

-

-

-

-

-

-

-

-

30

Treasury stock transactions (number of shares)

-

-

-

-

-

-

-

-

-

0

Gross issuance of vested restricted shares (number of shares)

-

-

-

-

-

-

-

-

-

1